SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
25-Apr-24 4:52 PM View: | Vaxcyte, Inc. (PCVX) | 23-Apr-24 | Option Exercise | 15,000 | $1.79 | $26,850.00 | 2% 772.57K to 787.57K | |
25-Apr-24 4:52 PM View: | Vaxcyte, Inc. (PCVX) | 23-Apr-24 | Planned Option Sale | 15,000 | $61.92 | $928,845.00 | (2%) 787.57K to 772.57K | |
03-Apr-24 4:21 PM View: | Vaxcyte, Inc. (PCVX) | 01-Apr-24 | Private Sale (Planned) | 2,616 | $66.71 | $174,502.00 | (< 1%) 775.19K to 772.57K | |
27-Mar-24 4:44 PM View: | Vaxcyte, Inc. (PCVX) | 25-Mar-24 | Option Exercise | 15,000 | $1.79 | $26,850.00 | 2% 775.19K to 790.19K | |
27-Mar-24 4:44 PM View: | Vaxcyte, Inc. (PCVX) | 25-Mar-24 | Planned Option Sale | 15,000 | $66.93 | $1,003,980.00 | (2%) 790.19K to 775.19K | |
13-Mar-24 4:22 PM View: | Vaxcyte, Inc. (PCVX) | 11-Mar-24 | Option Exercise | 65,000 | $2.03 | $131,950.00 | 9% 710.19K to 775.19K | |
04-Mar-24 9:19 PM View: | Vaxcyte, Inc. (PCVX) | 02-Mar-24 | Payment of Exercise | 7,967 | $71.55 | $570,039.00 | (1%) 718.15K to 710.19K | |
04-Mar-24 9:19 PM View: | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Sale (Planned) | 2,616 | $73.70 | $192,799.00 | (< 1%) 720.77K to 718.15K | |
04-Mar-24 9:19 PM View: | Vaxcyte, Inc. (PCVX) | 29-Feb-24 | Grant | 45,000 | -- | -- | 7% 675.77K to 720.77K | |
27-Feb-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 26-Feb-24 | Option Exercise | 30,000 | $1.79 | $53,700.00 | 4% 675.77K to 705.77K | |
27-Feb-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 26-Feb-24 | Planned Option Sale | 30,000 | $79.03 | $2,370,900.00 | (4%) 705.77K to 675.77K | |
27-Feb-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 23-Feb-24 | Option Exercise | 15,000 | $1.79 | $26,850.00 | 2% 675.77K to 690.77K | |
27-Feb-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 23-Feb-24 | Planned Option Sale | 15,000 | $76.21 | $1,143,210.00 | (2%) 690.77K to 675.77K | |
05-Feb-24 5:33 PM View: | Vaxcyte, Inc. (PCVX) | 01-Feb-24 | Private Sale (Planned) | 2,616 | $73.91 | $193,353.00 | (< 1%) 678.39K to 675.77K | |
31-Jan-24 4:11 PM View: | Vaxcyte, Inc. (PCVX) | 29-Jan-24 | Option Exercise | 30,000 | $1.79 | $53,700.00 | 4% 678.39K to 708.39K | |
31-Jan-24 4:11 PM View: | Vaxcyte, Inc. (PCVX) | 29-Jan-24 | Planned Option Sale | 30,000 | $66.03 | $1,980,900.00 | (4%) 708.39K to 678.39K | |
25-Jan-24 5:50 PM View: | Vaxcyte, Inc. (PCVX) | 23-Jan-24 | Option Exercise | 15,000 | $1.44 | $21,600.00 | 2% 678.39K to 693.39K | |
25-Jan-24 5:50 PM View: | Vaxcyte, Inc. (PCVX) | 23-Jan-24 | Planned Option Sale | 15,000 | $63.92 | $958,783.00 | (2%) 693.39K to 678.39K | |
04-Jan-24 4:24 PM View: | Vaxcyte, Inc. (PCVX) | 02-Jan-24 | Private Sale (Planned) | 2,616 | $63.89 | $167,144.00 | (< 1%) 681.0K to 678.39K | |
27-Dec-23 4:35 PM View: | Vaxcyte, Inc. (PCVX) | 26-Dec-23 | Option Exercise | 10,000 | $0.04 | $400.00 | 1% 686.0K to 696.0K | |
27-Dec-23 4:35 PM View: | Vaxcyte, Inc. (PCVX) | 26-Dec-23 | Planned Option Sale | 15,000 | $61.70 | $925,538.00 | (2%) 696.0K to 681.0K | |
27-Dec-23 4:35 PM View: | Vaxcyte, Inc. (PCVX) | 22-Dec-23 | Option Exercise | 9,900 | $2.03 | $20,097.00 | 1% 676.1K to 686.0K | |
05-Dec-23 4:15 PM View: | Vaxcyte, Inc. (PCVX) | 01-Dec-23 | Private Sale (Planned) | 2,618 | $52.12 | $136,442.00 | (< 1%) 678.72K to 676.1K | |
28-Nov-23 4:50 PM View: | Vaxcyte, Inc. (PCVX) | 24-Nov-23 | Private Sale (Planned) | 15,000 | $49.09 | $736,300.00 | (2%) 693.72K to 678.72K | |
03-Nov-23 4:29 PM View: | Vaxcyte, Inc. (PCVX) | 01-Nov-23 | Private Sale (Planned) | 2,618 | $47.29 | $123,813.00 | (< 1%) 696.34K to 693.72K | |
25-Oct-23 4:07 PM View: | Vaxcyte, Inc. (PCVX) | 23-Oct-23 | Private Sale (Planned) | 15,000 | $47.07 | $706,070.00 | (2%) 711.34K to 696.34K | |
04-Oct-23 4:06 PM View: | Vaxcyte, Inc. (PCVX) | 02-Oct-23 | Private Sale (Planned) | 2,618 | $50.42 | $131,996.00 | (< 1%) 713.96K to 711.34K | |
27-Sep-23 4:54 PM View: | Vaxcyte, Inc. (PCVX) | 25-Sep-23 | Private Sale (Planned) | 15,000 | $52.45 | $786,794.00 | (2%) 731.57K to 716.57K | |
27-Sep-23 4:54 PM View: | Vaxcyte, Inc. (PCVX) | 25-Sep-23 | Sale (Planned) | 2,618 | $52.43 | $137,264.00 | (< 1%) 716.57K to 713.96K | |
06-Sep-23 5:33 PM View: | Vaxcyte, Inc. (PCVX) | 05-Sep-23 | Payment of Exercise | 10,378 | $51.00 | $529,278.00 | (1%) 741.95K to 731.57K | |
31-Mar-23 4:36 PM View: | Athira Pharma, Inc. (ATHA) | 30-Mar-23 | Purchase | 15,000 | $2.47 | $37,050.00 | 139% 10.78K to 25.78K | |
31-Mar-23 4:36 PM View: | Athira Pharma, Inc. (ATHA) | 29-Mar-23 | Private Purchase | 10,000 | $2.33 | $23,300.00 | 1277% 0.78K to 10.78K | |
03-Mar-23 5:09 PM View: | Vaxcyte, Inc. (PCVX) | 02-Mar-23 | Payment of Exercise | 3,099 | $41.49 | $128,578.00 | (< 1%) 744.01K to 740.91K | |
03-Mar-23 5:09 PM View: | Vaxcyte, Inc. (PCVX) | 01-Mar-23 | Grant | 53,875 | -- | -- | 8% 690.14K to 744.01K | |
04-Jan-23 4:29 PM View: | Vaxcyte, Inc. (PCVX) | 30-Dec-22 | Option Exercise | 15,158 | $2.03 | $30,770.70 | 2% 674.98K to 690.14K | |
28-Sep-22 6:23 PM View: | Vaxcyte, Inc. (PCVX) | 26-Sep-22 | Private Sale (Planned) | 10,000 | $24.71 | $247,147.00 | (1%) 978.21K to 968.21K | |
19-Sep-22 4:37 PM View: | Vaxcyte, Inc. (PCVX) | 15-Sep-22 | Private Sale (Planned) | 11,000 | $27.95 | $307,413.00 | (1%) 989.21K to 978.21K | |
07-Sep-22 4:32 PM View: | Vaxcyte, Inc. (PCVX) | 02-Sep-22 | Payment of Exercise | 8,910 | $26.38 | $235,046.00 | (< 1%) 998.12K to 989.21K | |
30-Aug-22 4:16 PM View: | Vaxcyte, Inc. (PCVX) | 26-Aug-22 | Private Sale (Planned) | 10,000 | $27.44 | $274,416.00 | (< 1%) 1.01M to 998.12K | |
17-Aug-22 5:19 PM View: | Vaxcyte, Inc. (PCVX) | 15-Aug-22 | Private Sale (Planned) | 11,000 | $25.58 | $281,402.00 | (1%) 1.02M to 1.01M | |
28-Jul-22 5:02 PM View: | Vaxcyte, Inc. (PCVX) | 26-Jul-22 | Market Sale (Planned) | 10,000 | $23.27 | $232,664.00 | (< 1%) 1.03M to 1.02M | 2% |
19-Jul-22 5:12 PM View: | Vaxcyte, Inc. (PCVX) | 15-Jul-22 | Market Sale (Planned) | 11,000 | $24.47 | $269,187.00 | (1%) 1.04M to 1.03M | 7% |
28-Jun-22 5:14 PM View: | Vaxcyte, Inc. (PCVX) | 28-Jun-22 | Market Sale (Planned) | 10,000 | $21.00 | $210,000.00 | (< 1%) 1.05M to 1.04M | (8%) |
28-Jun-22 5:14 PM View: | Vaxcyte, Inc. (PCVX) | 24-Jun-22 | Market Sale (Planned) | 747 | $21.01 | $15,696.30 | (< 1%) 1.05M to 1.05M | (8%) |
23-Jun-22 5:48 PM View: | Vaxcyte, Inc. (PCVX) | 23-Jun-22 | Market Sale (Planned) | 3,541 | $21.01 | $74,410.20 | (< 1%) 1.05M to 1.05M | (8%) |
23-Jun-22 5:48 PM View: | Vaxcyte, Inc. (PCVX) | 22-Jun-22 | Market Sale (Planned) | 1,261 | $21.01 | $26,492.20 | (< 1%) 1.06M to 1.05M | (8%) |
23-Jun-22 5:48 PM View: | Vaxcyte, Inc. (PCVX) | 21-Jun-22 | Market Sale (Planned) | 5,451 | $21.05 | $114,736.00 | (< 1%) 1.06M to 1.06M | (8%) |
18-May-22 4:39 PM View: | Vaxcyte, Inc. (PCVX) | 16-May-22 | Option Exercise | 11,000 | $1.79 | $19,690.00 | 1% 1.06M to 1.07M | |
18-May-22 4:39 PM View: | Vaxcyte, Inc. (PCVX) | 16-May-22 | Planned Option Sale | 11,000 | $23.91 | $262,990.00 | (1%) 1.07M to 1.06M | |
20-Apr-22 4:54 PM View: | Vaxcyte, Inc. (PCVX) | 18-Apr-22 | Option Exercise | 11,000 | $1.79 | $19,690.00 | 1% 1.06M to 1.07M |